Pancreatic Adenocarcinoma | Norton Healthcare

Indication: Pancreatic Adenocarcinoma

A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife? System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma

Unresectable Stage 3

Device

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: AngioDynamics, Inc.

Learn more at ClinicalTrials.gov

Email for more information: mary.healey@louisville.edu

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.